Where this melanoma information comes from | Cancer Research UK
Cancer Research UK on Google+ Cancer Research UK on Facebook Cancer Research UK on Twitter

Where this melanoma information comes from

Men and women discussing melanoma skin cancer

On this page are the major sources of information that we use to put together this section.

 

About this page

All our information is checked by cancer specialists and surgeons who specialise in treating cancer. The names of our specialist reviewers are at the end of this list. We also try to find patients to review all our sections. If you have had malignant melanoma, live in the UK, and would like to become a patient reviewer, you can write to us by clicking on contact us.

 

Websites

Cancer Research UK
CancerStats Series

Cancer Atlas of the UK and Ireland
Chapter 14 – Melanoma of skin
Office for National Statistics

US National Cancer Institute (NCI)
Information on the treatment of melanoma 
LINK to the NCI information about melanoma

 

Books

Cancer principles and practice of oncology (10th edition)
De Vita VT, Lawrence TS and Rosenberg SA.
Wolters Kluwer Health, 2015

TNM (Tumour Node Metastases) Classification
Union International Contre le Cancer (UICC), 2009

Cancer Staging Manual (7th edition)
American Joint Committee on Cancer (AJCC), 2009

 

UK Guidelines

Melanoma: assessment and management
The National Institute for Health and Care Excellence (NICE), NG14, July, 2015
Link to the skin cancer guidance on the NICE website

Referral for suspected cancer. A clinical practice guideline.
The National Institute for Health and Care Excellence (NICE), June 2015
Link to the referral guidelines on the NICE website

Revised UK guidelines for the management of cutaneous melanoma 2010
J R Marsden and others. British Association of Dermatologists
Link to the melanoma management guidelines on the BAD website

Ipilimumab for advanced (unresectable or metastatic) melanoma in adults who have received prior therapy
The Scottish Medicines Consortium (SMC), May 2012
Link to SMC

Vemurafenib for advanced (unresectable or metastatic) melanoma 
The Scottish Medicines Consortium (SMC), September 2012
Link to SMC

Ipilimumab for advanced (unresectable or metastatic) melanoma in adults who have received prior therapy
The National Institute for Health and Clinical Excellence (NICE), TA268, December 2012
Link to the NICE website

Vemurafenib for advanced (unresectable or metastatic) melanoma
The National Institute for Health and Care Excellence (NICE), TA269, December 2012
Link to the NICE website

Dabrafenib for treating unresectable or metastatic BRAF V600 mutation‐positive melanoma
The National Institute for Health and Care Excellence (NICE), TA321, October 2014
Link to the NICE website

Ipilimumab for previously untreated advanced (unresectable or metastatic) melanoma
The National Institute for Health and Care Excellence (NICE), TA319, July 2014
Link to the NICE website

Dabrafenib for advanced BRAF V500 mutation positive melanoma
The Scottish Medicines Consortium (SMC), March 2015
Link to SMC 

Ipilimumab for previously untreated advanced (unresectable or metastatic) melanoma
The Scottish Medicines Consortium (SMC), November 2014
Link to SMC 

Pembrolizumab for advanced melanoma not previously treated with ipilimumab
 
The National Institute for Health and Care Excellence (NICE), TA366, November 2015
Link to the NICE website

Pembrolizumab for advanced melanoma not previously treated with ipilimumab
The Scottish Medicines Consortium (SMC), November 2015
Link to SMC 

Pembrolizumab for advanced melanoma previously treated with ipilimumab
The Scottish Medicines Consortium (SMC), November 2015
Link to SMC 

 

 

Articles and reviews

New drugs in melanoma: It's a whole new world. A M M Eggermont and C Robert. European Journal of Cancer. 47 (2011) pp 2150–2157.

Systematic Review of Medical Treatment in Melanoma: Current Status and Future Prospects. C Garbre and others. The Oncologist, 2011: 16:5–24.

Melanoma vaccines: developments over the past 10 years. O Klein and others. Expert reviews. June 2011, Vol. 10, No. 6, Pages 853–873.

Dormancy of metastatic melanoma. L Ossowski and J A Aguirre-Ghiso. Pigment cell melanoma research, 2010 Feb; 23(1): 41-56.

Staging of cutaneous melanoma. P Mohr and others. Annals of Oncology 20. Supplement 6. 2009.

 

Specialist reviewers

Dr Veronique Bataille MD PhD FRCPS
Mr Andrew Hayes MA PhD FRCS
Mr James Larkin MA MRCP PhD

 

Diagrams

Dee McLean – MeDee Art, Medical Illustration

Rate this page:
Submit rating
Rate this page
Rate this page for no comments box
Please enter feedback to continue submitting
Send feedback
Question about cancer? Contact our information nurse team

No Error

Updated: 9 December 2015